PhRMA’s Partnership for Prescription Assistance (
https://www.pparx.org/Intro.php) provides access to over 475 public-private patient assistance programs in USA(180 pharmaceutical biotechnology companies). Low income patients without healthcare insurance can enrol in a matching program and obtain free prescription drugs or drugs at a nominal cost. The eligibility conditions and income level vary in different states and programs. Over 5 million patients have benefited from prescription drug assistance. Similar programs exist in developing countries without national health insurance.
Amgen has a Safety Net program under the PhRMA scheme for Prolia, Xgeva (denosumab)
Safety Net® Foundation
Amgen
Contact Information
Safety Net Foundation
PO Box 13185
La Jolla, CA 92039-3185
1-(888) 762-6436 (phone)
1-(866) 549-7239 (fax)
How to Apply:
Select one of the links below to download the application or go to the program site for more information on how to apply. Once you fill out your application, send it to the address on the application. Do NOT send it to PPA.
Product Replacement Request Form
Spanish Facility Application Form
Spanish-Combined Patient Application Instructions and Patient Application Form
Notarized Income Statement
Facility Application Form
Product Prescription Form
Click here to visit the program's web site.
Eligibility:
Safety Net Foundation is designed to assist those patients who are uninsured and with limited or no financial resources. Eligibility is based on US residency, insurance status and income criteria. To enroll a patient, providers and patients should visit our website at
www.safetynetfoundation.com or call us at (888) 762-6436.
Other Information:
For Nplate™ Prolia™ and Sensipar® providers or patients should submit a Patient Enrollment Application for each patient to be considered for Foundation eligibility. Completion of the application form requires the patient's signature. For Aranesp®, EPOGEN®, Neulasta®,Nplate®, Vectibix®, and NEUPOGEN®: we recommend that providers call The Safety Net Foundation to pre-assess patients prior to submitting a form. Foundation staff can complete some portions of the application and send to the provider or patient for completion and signatures. The Safety Net Foundation reserves the right to approve or deny any Safety Net Foundation application or to modify or discontinue the program with respect to any patient or provider, or in its entirety, at any time. The Safety Net Foundation reserves the right to make an independent determination of eligibility in all cases
Product(s) covered by program:
Prolia™
Patients can ask for free samples from their doctors. The other alternative to enroll in clinical trials depending on the requirements and inclusion and exclusion criteria.
For poor patients without health insurance and unable to pay for medicines in cancer and heart diseases in developing countries, national and international health charities and manufacturing companies should be contacted to obtain treatment drugs. Mèdicins Sans Frontiéres MSF (
http://www.msf.org) provides emergency medical aid and treatment and essential medicines in 70 developing countries.